Jessica L Dodge, MD - Medicare Pathology in Danbury, CT

Jessica L Dodge, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Danbury, Connecticut. She went to Medical College Of Pennsylvania and graduated in 1996 and has 28 years of diverse experience with area of expertise as Pathology. She is a member of the group practice Saint Francis Care Medical Group Pc and her current practice location is 24 Hospital Ave, Department Of Pathology, Danbury, Connecticut. You can reach out to her office (for appointments etc.) via phone at (203) 739-7034.

Jessica L Dodge is licensed to practice in Massachusetts (license number 218973) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1134176522.

Contact Information

Jessica L Dodge, MD
24 Hospital Ave, Department Of Pathology,
Danbury, CT 06810-6099
(203) 739-7034
Not Available



Physician's Profile

Full NameJessica L Dodge
GenderFemale
SpecialityPathology
Experience28 Years
Location24 Hospital Ave, Danbury, Connecticut
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jessica L Dodge attended and graduated from Medical College Of Pennsylvania in 1996
  NPI Data:
  • NPI Number: 1134176522
  • Provider Enumeration Date: 05/30/2006
  • Last Update Date: 08/29/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 4880598630
  • Enrollment ID: I20071217000718

Medical Identifiers

Medical identifiers for Jessica L Dodge such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1134176522NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 218973 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Saint Mary's HospitalWaterbury, CTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Saint Francis Care Medical Group Pc327443684520

News Archive

Changing one atom in InsP6 inhibitor can increase its ability to neutralize toxins in the gut

Infections with bacterium Clostridium difficile have rapidly become a significant medical problem in hospitals and long-term care facilities. The bacteria cause diarrhea and life-threatening inflammation of the colon by producing toxins that kill the endothelial cells that form the lining of the gut.

Amarin raises $70 million through private placement

Amarin Corporation plc today announced it has closed its $70 million private placement. The transaction was led by existing investor, Fountain Healthcare Partners, on behalf of funds affiliated with other existing investors Sofinnova Ventures, Orbimed Advisors and Longitude Capital. The new investor group was led by funds affiliated with Abingworth LLP and included APG Asset Management, Great Point Partners, Tavistock Life Sciences Company and RA Capital. Cowen and Company, LLC acted as the exclusive placement agent for the transaction.

Pathway Medical initiates enrollment in JETSTREAM G3 Calcium Study in peripheral artery disease

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced enrollment of the first patient in the company's JETSTREAM G3 Calcium Study, a prospective, single-arm, multi-center registry to evaluate the treatment effects of the JETSTREAM G3 System in patients with moderate to severely calcified peripheral artery disease.

Health care system or patient-directed programs help prevent or manage diabetes

A new study has found that programs aimed at helping people prevent or manage diabetes are most successful if they are directed at the patient or the health care system. Programs aimed at physicians were only successful for patients with poorer diabetes control.

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jessica L Dodge allows following entities to bill medicare on her behalf.
Entity NameSaint Francis Care Medical Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760690101
PECOS PAC ID: 3274436845
Enrollment ID: O20040130000318

News Archive

Changing one atom in InsP6 inhibitor can increase its ability to neutralize toxins in the gut

Infections with bacterium Clostridium difficile have rapidly become a significant medical problem in hospitals and long-term care facilities. The bacteria cause diarrhea and life-threatening inflammation of the colon by producing toxins that kill the endothelial cells that form the lining of the gut.

Amarin raises $70 million through private placement

Amarin Corporation plc today announced it has closed its $70 million private placement. The transaction was led by existing investor, Fountain Healthcare Partners, on behalf of funds affiliated with other existing investors Sofinnova Ventures, Orbimed Advisors and Longitude Capital. The new investor group was led by funds affiliated with Abingworth LLP and included APG Asset Management, Great Point Partners, Tavistock Life Sciences Company and RA Capital. Cowen and Company, LLC acted as the exclusive placement agent for the transaction.

Pathway Medical initiates enrollment in JETSTREAM G3 Calcium Study in peripheral artery disease

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced enrollment of the first patient in the company's JETSTREAM G3 Calcium Study, a prospective, single-arm, multi-center registry to evaluate the treatment effects of the JETSTREAM G3 System in patients with moderate to severely calcified peripheral artery disease.

Health care system or patient-directed programs help prevent or manage diabetes

A new study has found that programs aimed at helping people prevent or manage diabetes are most successful if they are directed at the patient or the health care system. Programs aimed at physicians were only successful for patients with poorer diabetes control.

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jessica L Dodge is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jessica L Dodge, MD
24 Hospital Ave, Department Of Pathology,
Danbury, CT 06810-6099

Ph: (203) 739-7034
Jessica L Dodge, MD
24 Hospital Ave, Department Of Pathology,
Danbury, CT 06810-6099

Ph: (203) 739-7034

News Archive

Changing one atom in InsP6 inhibitor can increase its ability to neutralize toxins in the gut

Infections with bacterium Clostridium difficile have rapidly become a significant medical problem in hospitals and long-term care facilities. The bacteria cause diarrhea and life-threatening inflammation of the colon by producing toxins that kill the endothelial cells that form the lining of the gut.

Amarin raises $70 million through private placement

Amarin Corporation plc today announced it has closed its $70 million private placement. The transaction was led by existing investor, Fountain Healthcare Partners, on behalf of funds affiliated with other existing investors Sofinnova Ventures, Orbimed Advisors and Longitude Capital. The new investor group was led by funds affiliated with Abingworth LLP and included APG Asset Management, Great Point Partners, Tavistock Life Sciences Company and RA Capital. Cowen and Company, LLC acted as the exclusive placement agent for the transaction.

Pathway Medical initiates enrollment in JETSTREAM G3 Calcium Study in peripheral artery disease

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced enrollment of the first patient in the company's JETSTREAM G3 Calcium Study, a prospective, single-arm, multi-center registry to evaluate the treatment effects of the JETSTREAM G3 System in patients with moderate to severely calcified peripheral artery disease.

Health care system or patient-directed programs help prevent or manage diabetes

A new study has found that programs aimed at helping people prevent or manage diabetes are most successful if they are directed at the patient or the health care system. Programs aimed at physicians were only successful for patients with poorer diabetes control.

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

Read more News

› Verified 7 days ago


Pathology Doctors in Danbury, CT

Samuel P Barasch, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 24 Hospital Ave, Danbury, CT 06810
Phone: 203-739-7453    
Marcelo Ferreira Cassini, M.D., PH.D.
Pathology
Medicare: Medicare Enrolled
Practice Location: 24 Hospital Ave Dept Of, Danbury, CT 06810
Phone: 203-739-7034    
Hani El Fanek, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 24 Hospital Ave, Danbury, CT 06810
Phone: 203-797-7306    
Ramapriya Vidhun, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 24 Hospital Ave, Danbury, CT 06810
Phone: 203-797-7306    
Mary S Chacho, M.D.
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 24 Hospital Ave, Danbury, CT 06810
Phone: 203-739-7453    
Dr. Gunjan Gupta, MD, PHD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 24 Hospital Ave, Department Of Pathology And Laboratory Medicine, Danbury, CT 06810
Phone: 203-739-6471    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.